MediWound Ltd

(NASDAQ:MDWD)

Latest On MediWound Ltd (MDWD):

Date/Time Type Description Signal Details
2023-05-31 22:31 ESTNewsMediWound: With Expenses Covered, Growth Is Within ReachN/A
2023-05-30 17:26 ESTNewsMediWound GAAP EPS of -$0.44 misses by $0.26, revenue of $3.8M misses by $1.35MN/A
2023-05-30 17:26 ESTNewsMediWound Ltd. (MDWD) Q1 2023 Earnings Call TranscriptN/A
2023-05-30 17:26 ESTNewsMediWound slips after Q1 missN/A
2023-05-27 03:57 ESTNewsMediWound Q1 Earnings PreviewN/A
2023-03-16 20:36 ESTNewsMediWound names industry veteran as CFON/A
2023-03-16 20:36 ESTNewsMediWoundEPS of -$1.18, revenue of $11.62M beats by $5.02MN/A
2023-03-16 20:36 ESTNewsMediWound Ltd. (MDWD) Q4 2022 Earnings Call TranscriptN/A
2023-03-15 13:53 ESTNewsMediWound Q4 2022 Earnings PreviewN/A
2023-01-04 21:36 ESTNewsMediWound: Gaining TractionN/A
2022-12-29 20:29 ESTNewsMediWound, Vericel gain on FDA approval of burn therapyN/A
2022-12-23 10:45 ESTNewsMediWound's burn treatment Nexobrid approved in JapanN/A
2022-12-20 15:02 ESTNewsMediWound gets Swiss marketing approval for burns treatment NexoBridN/A
2022-12-06 04:24 ESTNewsMediWound announces 1-for-7 reverse share splitN/A
2022-11-15 21:57 ESTNewsMediWound GAAP EPS of -$0.13 misses by $0.03, revenue of $5.8M beats by $1.2MN/A
2022-11-15 21:57 ESTNewsMediWound Ltd. (MDWD) Q3 2022 Earnings Call TranscriptN/A
2022-11-15 04:52 ESTNewsMediWound Q3 2022 Earnings PreviewN/A
2022-09-22 20:26 ESTNewsMediWound stock slips on ~$30.5M securities offeringsN/A
2022-09-20 19:14 ESTNewsMediWound's NexoBrid for thermal burns in children gets EMA reviewN/A
2022-08-10 02:57 ESTNewsMediWound GAAP EPS of -$0.13 misses by $0.03, revenue of $4.67M misses by $0.61MN/A
2022-08-10 02:57 ESTNewsMediWound Ltd. (MDWD) CEO Ofer Gonen on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-10 02:57 ESTNewsMediWound Ltd. 2022 Q2 - Results - Earnings Call PresentationN/A
2022-08-09 05:06 ESTNewsMediWound Q2 Earnings PreviewN/A
2022-08-03 23:17 ESTNewsMediWound refiling for NexoBrid to treat severe thermal burns gets FDA reviewN/A
2022-07-07 15:49 ESTNewsMediWound adds 13% after favorable data for ulcer candidateN/A
2022-06-30 13:41 ESTNewsMediWound taps Tzvi Palash as COON/A
2022-05-17 12:25 ESTNewsMediWound GAAP EPS of -$0.12 misses by $0.01, revenue of $4.4M beats by $0.11MN/A
2022-05-17 12:25 ESTNewsMediWound picks industry veteran for CEO roleN/A
2022-05-17 12:25 ESTNewsMediWound Ltd. (MDWD) CEO Sharon Malka on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-16 15:11 ESTNewsMediWound Q1 2022 Earnings PreviewN/A
2022-03-17 15:21 ESTNewsMediWound Q4 2021 Earnings PreviewN/A
2022-03-17 15:20 ESTNewsMediWound GAAP EPS of -$0.15 in-line, revenue of $5.49M misses by $0.05MN/A
2022-03-17 15:19 ESTNewsMediWound Ltd. (MDWD) CEO Sharon Malka on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-03 14:30 ESTNewsMediWound slumps on pricing $10M stock offeringN/A
2022-03-02 20:11 ESTNewsMediWound slides on proposed stock offeringN/A
2022-02-10 11:47 ESTNewsMediWound wins $9M additional BARDA funding for NexoBridN/A
2022-01-24 07:28 ESTNewsMediWound reports positive results from Phase 2 trial of EscharEx for debridement of chronic woundsN/A
2021-12-20 10:51 ESTNewsMediWound reports positive initial data from Phase 2 EscharEx study in chronic, hard to heal woundsN/A
2021-11-17 00:12 ESTNewsMediWound EPS beats by $0.01, beats on revenueN/A
2021-11-17 00:12 ESTNewsMediWound Ltd. (MDWD) CEO Sharon Malka on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-16 04:19 ESTNewsMediWound Q3 2021 Earnings PreviewN/A
2021-10-13 04:34 ESTNewsWarning: MDWD is at high risk of performing badlyN/A
2021-10-06 12:47 ESTNewsMDWD is at high risk of performing badlyN/A
2021-09-27 21:29 ESTNewsWarning: MDWD has been downgraded to Very BearishN/A
2021-09-22 00:18 ESTNewsWarning: MDWD has been downgraded to Very Bearish.N/A
2021-08-11 04:24 ESTNewsMediwound Ltd (MDWD) CEO Sharon Malka on Q2 2021 Results - Earnings Call TranscriptN/A
2021-08-10 07:32 ESTNewsMediWound EPS misses by $0.01, beats on revenueN/A
2021-07-30 17:24 ESTNewsMediWound: Disappointing Thus Far But Still A Strong BuyN/A
2021-07-29 01:24 ESTNewsMediWound: Adjusting My Strategy After NexoBrid CRLN/A
2021-07-21 15:33 ESTNewsMediWound completes enrollment for interim assessment of mid-stage EscharEx studyN/A

About MediWound Ltd (MDWD):

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; MWPC005, a topically applied biological drug candidate that is in Phase I/II clinical trial for the treatment of non-melanoma skin cancers; and MWPC003 for connective tissue disorders. MediWound Ltd. was founded in 2000 and is headquartered in Yavne, Israel.

MDWD Quotes by TradingView

See Advanced Chart

General

  • Name MediWound Ltd
  • Symbol MDWD
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 75
  • Fiscal Year EndDecember
  • IPO Date2014-03-20
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.mediwound.com
View More

Valuation

  • Trailing PE 27.07
  • Price/Sales (Trailing 12 Mt.) 7.03
  • Price/Book (Most Recent Quarter) 21.05
  • Enterprise Value Revenue 6.13
  • Enterprise Value EBITDA 15.35
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$0.24
  • Next Year EPS Estimate -$0.54
  • Next Quarter EPS Estimate -$0.12
  • Profit Margin -42%
  • Operating Margin -40%
  • Return on Assets -15%
  • Return on Equity -83%
  • Revenue 21.76 million
  • Earnings Per Share $0.24
  • Revenue Per Share $0.8
  • Gross Profit 7.55 million
  • Quarterly Earnings Growth 22.6%
View More

Highlights

  • Market Capitalization 155.8 million
  • EBITDA 8.18 million
  • PE Ratio -9.93
  • PEG Ratio -0.07
  • Analyst Target Price $7.67
  • Book Value Per Share $0.27
View More

Share Statistics

  • Shares Outstanding 27.24 million
  • Shares Float 16.8 million
  • % Held by Insiders 4277%
  • % Held by Institutions 18.85%
  • Shares Short 33009
  • Shares Short Prior Month 21560
  • Short Ratio 0.22
View More

Technicals

  • Beta 1.54
  • 52 Week High $6.07
  • 52 Week Low $1.44
  • 50 Day Moving Average 5.41
  • 200 Day Moving Average 4.22
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

MediWound Ltd (MDWD) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

MediWound Ltd (MDWD) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-25$N/A-$0.06-$0.1145.45%
2020-09-302020-11-10$6.63 million-$0.07-$0.1027.08%
2020-06-302020-08-06$N/A-$0.11-$0.128.33%
2020-03-312020-05-20$4.44 million-$0.09-$0.1436.84%
2019-12-312020-02-25$5.44 million-$0.13-$0.10-25%
2019-09-302019-11-14$5.14 million-$0.11-$0.1315.38%
2019-06-302019-08-12$20.75 million$0.47-$0.031907.69%
2019-03-312019-05-21$461000-$0.15-$0.14-7.14%
2018-12-312019-03-25$992000$0.22-$0.15244.74%
2018-09-302018-11-13$858000-$0.11-$0.2043.88%
2018-06-302018-08-07$1.03 million-$0.15-$0.2023.47%
2018-03-312018-05-10$520000-$0.17-$0.14-25.93%
2017-12-312018-03-19$530000-$0.08-$0.1854.93%
2017-09-302017-11-16$739000-$0.16-$0.1915.79%
2017-06-302017-08-03$687000-$0.20-$0.20-2.04%
2017-03-312017-05-08$540000-$0.20-$0.17-19.05%
2016-12-312017-02-21$430000-$0.09-$0.2563.71%
2016-09-302016-11-14$518000-$0.26-$0.26-0.97%
2016-06-302016-07-28$356000-$0.34-$0.24-42.68%
2016-03-312016-04-21$254000-$0.17-$0.2429.52%
2015-12-312016-01-25$267000-$0.36-$0.23-54.51%
2015-09-302015-10-27$102000-$0.17-$0.3145.16%
2015-06-302015-08-03$165000-$0.19-$0.2626.92%
2015-03-312015-05-04$67000-$0.30-$0.25-20%
2014-12-312015-02-12$124000-$0.33-$0.26-26.92%
2014-09-302014-11-05$46000-$0.24-$0.240%
2014-06-302014-07-31$39000-$0.28-$0.17-64.71%
2014-03-312014-05-02$50000-$0.05-$0.1770.59%

MediWound Ltd (MDWD) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

MediWound Ltd (MDWD) Chart:

MDWD chart by TradingView

MediWound Ltd (MDWD) News:

Below you will find a list of latest news for MediWound Ltd (MDWD) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

MediWound Ltd (MDWD) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-03-21514.26CALL0 0141.29TRUE00
2025-03-217.510.75CALL0 0115.79TRUE00
2025-03-21100CALL0 093.91TRUE00
2025-03-2112.50CALL0 080.3TRUE00
2025-03-21156.6CALL0 578.24TRUE00
2025-03-2117.55.11CALL0 576.73FALSE00
2025-03-21202.5CALL0 4174.78FALSE00
2025-03-2122.50CALL0 00FALSE00
2025-03-21250CALL0 00FALSE00
2025-03-21300CALL0 00FALSE00
2025-03-21350CALL0 00FALSE00
2025-03-2150PUT0 00FALSE00
2025-03-217.50PUT0 00FALSE00
2025-03-21100.7PUT0 10FALSE00
2025-03-2112.51.2PUT0 10FALSE00
2025-03-21152.4PUT0 988.5FALSE00
2025-03-2117.53.12PUT0 259.07TRUE00
2025-03-21200PUT0 065.06TRUE00
2025-03-2122.50PUT0 046.2TRUE00
2025-03-21250PUT0 049.09TRUE00
2025-03-21300PUT0 054.2TRUE00
2025-03-21350PUT0 0118.49TRUE00

Latest MDWD Trades:

Date Shares Price
Jun 13, 2022 2:52 PM EST200$1.74

MediWound Ltd (MDWD) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891320001946/0001178913-20-001946-index.htm
2019-04-08UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1593984/000000000019006753/0000000000-19-006753-index.htm
2017-02-09SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000090221917000257/0000902219-17-000257-index.htm
2017-08-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000090221917000560/0000902219-17-000560-index.htm
2018-02-08SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000090221918000039/0000902219-18-000039-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000090221919000059/0000902219-19-000059-index.htm
2020-01-28SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000090221920000291/0000902219-20-000291-index.htm
2020-06-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000090221920000393/0000902219-20-000393-index.htm
2017-01-31SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000117891317000232/0001178913-17-000232-index.htm
2017-01-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891317000245/0001178913-17-000245-index.htm
2017-02-01SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000117891317000255/0001178913-17-000255-index.htm
2017-02-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891317000291/0001178913-17-000291-index.htm
2017-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000117891317000310/0001178913-17-000310-index.htm
2017-02-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891317000371/0001178913-17-000371-index.htm
2017-02-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891317000573/0001178913-17-000573-index.htm
2017-02-2120-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1593984/000117891317000577/0001178913-17-000577-index.htm
2017-05-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891317001307/0001178913-17-001307-index.htm
2017-05-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891317001527/0001178913-17-001527-index.htm
2017-05-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891317001531/0001178913-17-001531-index.htm
2017-06-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891317001883/0001178913-17-001883-index.htm
2017-07-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891317002090/0001178913-17-002090-index.htm
2017-08-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891317002253/0001178913-17-002253-index.htm
2017-09-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891317002600/0001178913-17-002600-index.htm
2017-09-05SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000117891317002608/0001178913-17-002608-index.htm
2017-09-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891317002630/0001178913-17-002630-index.htm
2017-09-18424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1593984/000117891317002691/0001178913-17-002691-index.htm
2017-09-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891317002695/0001178913-17-002695-index.htm
2017-09-19424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1593984/000117891317002697/0001178913-17-002697-index.htm
2017-09-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891317002703/0001178913-17-002703-index.htm
2017-10-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891317002869/0001178913-17-002869-index.htm
2017-10-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891317002900/0001178913-17-002900-index.htm
2017-11-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891317003131/0001178913-17-003131-index.htm
2017-11-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891317003176/0001178913-17-003176-index.htm
2018-01-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891318000170/0001178913-18-000170-index.htm
2018-01-22SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000117891318000211/0001178913-18-000211-index.htm
2018-01-31SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000117891318000314/0001178913-18-000314-index.htm
2018-02-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000117891318000365/0001178913-18-000365-index.htm
2018-02-08SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000117891318000428/0001178913-18-000428-index.htm
2018-02-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891318000676/0001178913-18-000676-index.htm
2018-03-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891318000885/0001178913-18-000885-index.htm
2018-03-1920-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1593984/000117891318000887/0001178913-18-000887-index.htm
2018-03-19S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1593984/000117891318000892/0001178913-18-000892-index.htm
2018-05-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891318001565/0001178913-18-001565-index.htm
2018-05-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891318001584/0001178913-18-001584-index.htm
2018-06-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891318001883/0001178913-18-001883-index.htm
2018-06-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891318001923/0001178913-18-001923-index.htm
2018-06-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891318001929/0001178913-18-001929-index.htm
2018-08-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891318002304/0001178913-18-002304-index.htm
2018-09-246-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891318002568/0001178913-18-002568-index.htm
2018-11-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891318002903/0001178913-18-002903-index.htm
2019-01-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891319000121/0001178913-19-000121-index.htm
2019-02-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000117891319000309/0001178913-19-000309-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000117891319000381/0001178913-19-000381-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000117891319000454/0001178913-19-000454-index.htm
2019-03-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891319000792/0001178913-19-000792-index.htm
2019-03-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891319000909/0001178913-19-000909-index.htm
2019-03-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891319000911/0001178913-19-000911-index.htm
2019-03-2520-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1593984/000117891319000913/0001178913-19-000913-index.htm
2019-03-25S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1593984/000117891319000920/0001178913-19-000920-index.htm
2019-03-25F-3Registration statement by foreign private issuershttps://www.sec.gov/Archives/edgar/data/1593984/000117891319000922/0001178913-19-000922-index.htm
2019-03-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891319000924/0001178913-19-000924-index.htm
2019-04-12CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1593984/000117891319001120/0001178913-19-001120-index.htm
2019-04-18CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1593984/000117891319001183/0001178913-19-001183-index.htm
2019-05-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891319001289/0001178913-19-001289-index.htm
2019-05-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891319001363/0001178913-19-001363-index.htm
2019-05-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891319001559/0001178913-19-001559-index.htm
2019-05-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891319001605/0001178913-19-001605-index.htm
2019-06-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891319001690/0001178913-19-001690-index.htm
2019-07-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891319001934/0001178913-19-001934-index.htm
2019-08-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891319002149/0001178913-19-002149-index.htm
2019-08-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891319002192/0001178913-19-002192-index.htm
2019-08-236-K/AReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891319002251/0001178913-19-002251-index.htm
2019-09-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891319002438/0001178913-19-002438-index.htm
2019-10-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891319002449/0001178913-19-002449-index.htm
2019-10-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891319002453/0001178913-19-002453-index.htm
2019-11-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891319002734/0001178913-19-002734-index.htm
2019-12-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891319002874/0001178913-19-002874-index.htm
2020-01-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891320000022/0001178913-20-000022-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000117891320000279/0001178913-20-000279-index.htm
2020-02-06SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000117891320000291/0001178913-20-000291-index.htm
2020-02-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891320000638/0001178913-20-000638-index.htm
2020-02-2520-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1593984/000117891320000640/0001178913-20-000640-index.htm
2020-02-25424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1593984/000117891320000647/0001178913-20-000647-index.htm
2020-02-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891320000649/0001178913-20-000649-index.htm
2020-02-25S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1593984/000117891320000651/0001178913-20-000651-index.htm
2020-03-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891320000684/0001178913-20-000684-index.htm
2020-03-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891320000956/0001178913-20-000956-index.htm
2020-04-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891320001215/0001178913-20-001215-index.htm
2020-05-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891320001535/0001178913-20-001535-index.htm
2020-05-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891320001551/0001178913-20-001551-index.htm
2020-06-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891320001896/0001178913-20-001896-index.htm
2020-07-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891320001946/0001178913-20-001946-index.htm
2020-08-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891320002286/0001178913-20-002286-index.htm
2020-08-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891320002493/0001178913-20-002493-index.htm
2020-09-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891320002640/0001178913-20-002640-index.htm
2020-10-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891320002913/0001178913-20-002913-index.htm
2020-10-306-K/AReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1593984/000117891320002949/0001178913-20-002949-index.htm
2017-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000119312517043820/0001193125-17-043820-index.htm
2018-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000119312518045765/0001193125-18-045765-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000119312519039173/0001193125-19-039173-index.htm
2019-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000121390019002073/0001213900-19-002073-index.htm
2020-01-27SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1593984/000121390020001894/0001213900-20-001894-index.htm
2019-04-22EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1593984/999999999519000785/9999999995-19-000785-index.htm
2017-02-28CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1593984/999999999717001269/9999999997-17-001269-index.htm
2017-03-20CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1593984/999999999717003766/9999999997-17-003766-index.htm
2019-04-09CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1593984/999999999719002564/9999999997-19-002564-index.htm